Neutrophil-Lymphocyte Ratio (Nlr) And Erythrocyte Sedimentation Rate (Esr) Correlation In Covid-19 Patients At Hermina Hospital Medan
Keywords:
Covid-19, Neutrophil-Lymphocyte Ratio (NLR), Erythrocyte Sedimentation Rate (ESR)Abstract
Background: WHO in February 2020 officially announced the name of the mysterious pneumonia as Coronavirus Disease (COVID-19). COVID-19 is caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) virus. The Corona virus can be transmitted from human to other humans and WHO on March 12 2020 finally declared COVID-19 a global pandemic. Laboratory tests are used to determine the degree of severity so that appropriate treatment will be carried out. Purpose: This study aims to determine the relationship between the Neutrophil-Lymphocyte Ratio (NLR) and Erythrocyte Sedimentation Rate (ESR) in COVID-19 patients at Hermina Hospital Medan Method: This research is an observational correlation analytic study with a cross-sectional approach conducted at Hermina Hospital Medan against 54 research samples. Results: From this study it is known that the majority of confirmed COVID-19 patients who came to Hermina Medan Hospital were in the age group of 41-50 years and were female. The NLR value in patients with confirmed COVID-19 with the lowest score was 1.4, the highest was 46.50, and the average was 12.91. The ESR value in patients with confirmed COVID-19 with the lowest score was 10, the highest was 92, and the median was 51.12. The results showed that there was a correlation between NLR and CRP values (p = <0.001) with a low correlation strength (r = 0.354) Conclusion: A correlation was found between NLR and ESR but with a low correlation strength, so it can be concluded that the use of ESR to replace ESR value as a biomarker in COVID-19 patients is less precise
References
Susilo A, Rumende CM, Pitoyo CW, Santoso WD, Yulianti M, Herikurniawan, dkk. Penyakit Coronavirus 2019: Tinjauan Literatur Saat Ini. J Penyakit Dalam Indonesia. 2020;7(1):45–67.
Taj S, Kashif A, Fatima SA, Imran S, Lone A, Ahmed Q. Peran Parameter Hematologi dalam Stratifikasi Keparahan Penyakit COVID-19. Ann Medi Surg. 2021;62:68–72.
Duz ME, Balci A, tingkat Menekse E.D-dimer dan tingkat keparahan COVID-19. Klin Calisma Res Artik. 2020;68(4):353-360.
Silva LHAC, Carvalho DCM, Lima E de A, Galvao JGFM, Silva JS de F, Neto JM de S, dkk. Neutrofil dan COVID-19: Jalan sejauh ini. Int Immunofarmakol. 2021;90:2-7.
Yuliana. Penyakit Virus Corona (COVID-19); Sebuah Literatur Tinjauan. Wellness Heal Mag J. 2020;2(1):187–92.
Peta Risiko [Internet]. Kementerian Kesehatan RI. 2021. Tersedia dari:https://covid19.go.id/peta-risiko
Singhal T. Review Coronavirus Disease-2019 (COVID-19). India J Pediatr. 2020;87(4):281–286.
Lotfi M, Hamblin MR, Rezaei N. COVID-19: Penularan, pencegahan, dan potensi peluang terapeutik. Klinik Chim Acta. 2020;508:254–66.
Sheeren MA, Khan S, Kazmi A, Bashir N, Rabeea S. Infeksi COVID-19: Asal, penularan, dan karakteristik virus korona manusia. J Adv Res. 2020; 24:91–98.
Jin Y, Yang H, Ji W, Wu W, Chen S, Zhang W, dkk. Virologi, Epidemiologi, Patogenesis, dan Pengendalian COVID-19. Virus J. 2020;12(4):2-17.
Ge H, Wang X, Yuan X, Xiao G, Wang C, Deng T, dkk. Epidemiologi dan informasi klinis tentang COVID-19. Eur J Clin Mikrobiol Menginfeksi Dis. 2020;
Chatterjee SK, Saha S, Munoz MNM. Patogenesis Molekuler, Imunopatogenesis, dan Strategi Terapi Baru Melawan COVID-19. Biosci Mol Depan. 2020;7:1-11.
Haque SM, Ashwaq O, Sarief A, Mohamed AKAJ. Ulasan komprehensif tentang SARS-CoV-2. Virol masa depan. 2020;15(9):625–648.
Lee C, Choi WJ. Gambaran umum patogenesis inflamasi COVID-19 dari perspektif terapeutik. Res Farmasi. 2021;44:99–116.
Menjadirnstein RR. Pola Aktivasi Reseptor Bawaan yang Melibatkan Sinergisme TLR dan NLR dalam Badai Sitokin COVID-19, ALI/ARDS, dan Sepsis: Tinjauan dan Pembuatan Model Prediksi Baru dan Saran Terapi. Int J Mol Sci. 2021;22:2–44.
Paz LO, Capodanno D, Montalescot G, Angiolillo DJ. Penyakit Coronavirus 2019–Trombosis dan Koagulopati Terkait: Tinjauan Karakteristik Patofisiologis dan Implikasinya untuk Manajemen Antitrombotik. J Am Heart Assoc. 2021;10:1–24.
Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, dkk. Karakteristik dan Hasil dari 21 Pasien Sakit Kritis Dengan COVID-19 di Negara Bagian Washington. JAMA- J. 2020;323(16):1612–1614.
Hall J, Hall M. Guyton dan Hall Textbook of Medical Physiology. 14t
Salehi S, Abedi A, Balakrishnan S, Gholamrezanezhad A. Penyakit Coronavirus 2019 (COVID-19): Tinjauan Sistematis Temuan Pencitraan pada 919 Pasien. Pencitraan Kardiopulm. 2020;215(1):87–93.
